• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Short Line Bus Company 14-Jan-02


New York District

Food & Drug Administration

300 Pearl Street, Suite 100

Buffalo, NY 14202




January 14, 2002

George Grieve, President

Chenango Valley Bus Lines

Short Line Bus Company

4 Leisure Lane

Mahwah, NJ 07430

Dear Mr. Grieve:

During the November 16, 2001 inspection of your bus service area facility located ~t 123 Eldredge Street, Binghamton, NY, Investigator Sonia Ortiz-Latinsky observed a violation o the U.S. Public Health Service Act and its implementing regulations for the Control of Communicable Diseases and Interstate Conveyance Sanitation (Title 21, Code of Federal Regulations, Parts 1240 and 1250).

At the conclusion of the inspection, the investigator presented the Inspectional Observations (Form FDA 483) and Inspection Summary ? Bus Service Area Sanitation (Form FDA 589), copies of which are enclosed, to Joann C. Sadowski, General Manager, and discussed the findings with her. The following deficiency was observed:

There is no backflow preventer device in the water line leading to the hose used for flushing and washing the waste tank. Location ? Bus Servicing Area.

As of the date of this letter, we have not received written documentation of your promised corrective action. This letter is not intended to be an all-inclusive list of deficiencies that may exist. As a result of these inspectional findings, a "Provisional" classification has been assigned for 30 day period. A re-inspection will be conducted. If significant improvements have not been ma e at that time, a "Not Approved" classification will be justified.

You should take prompt action to correct this deficiency. It is your responsibility o ensure that all requirements of the U.S. Public Health Service Act and its implementing regulations are being met. You should notify this office in writing, within 15 working days of receipt of is letter, of the specific steps you have taken to correct each of the noted violations.

Your response should be sent to the Food and Drug Administration, 300 Pearl Street, Suite 100, Buffalo, New York 14202, Attention: Patricia A. Clark, Compliance Officer. If you have any questions, you can call Ms. Clark at 716-551-4461, ext. 3168.


Jerome G. Woyshner

Director, New York District